Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Dysuria, Insomnia, Myalgia, Pain, Pain of skin
Clinical narrative: skin tenderness on his right arm specifically under his right humorous and from his nipple line to his hips on his torso; he felt pain and an urge to urinate; took a muscle relaxer last night to help him sleep but that also didn't help; achiness; shivering; sore; discomfort; rash has been growing from his lower back and abdomen concentrated on his right side; lower back, hip and abdominal pain; slight rash in the injection site; lower back, hip and abdominal pain; lower back, hip and abdominal pain; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of INSOMNIA (took a muscle relaxer last night to help him sleep but that also didn't help), ABDOMINAL PAIN (lower back, hip and abdominal pain), PAIN OF SKIN (skin tenderness on his right arm specifically under his right humorous and from his nipple line to his hips on his torso), DYSURIA (he felt pain and an urge to urinate) and BACK PAIN (lower back, hip and abdominal pain) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Herniated disc. Concomitant products included VITAMIN C [ASCORBIC ACID] and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced ABDOMINAL PAIN (lower back, hip and abdominal pain), BACK PAIN (lower back, hip and abdominal pain), RASH (rash has been growing from his lower back and abdomen concentrated on his right side), ARTHRALGIA (lower back, hip and abdominal pain) and VACCINATION SITE RASH (slight rash in the injection site). On 26-Jan-2021, the patient experienced PAIN (sore), DISCOMFORT (discomfort), MYALGIA (achiness) and CHILLS (shivering). On 31-Jan-2021, the patient experienced INSOMNIA (took a muscle relaxer last night to help him sleep but that also didn't help) and DYSURIA (he felt pain and an urge to urinate). On an unknown date, the patient experienced PAIN OF SKIN (skin tenderness on his right arm specifically under his right humorous and from his nipple line to his hips on his torso). On 27-Jan-2021, CHILLS (shivering) had resolved. At the time of the report, INSOMNIA (took a muscle relaxer last night to help him sleep but that also didn't help), ABDOMINAL PAIN (lower back, hip and abdominal pain), PAIN OF SKIN (skin tenderness on his right arm specifically under his right humorous and from his nipple line to his hips on his torso), DYSURIA (he felt pain and an urge to urinate), BACK PAIN (lower back, hip and abdominal pain), PAIN (sore), DISCOMFORT (discomfort), RASH (rash has been growing from his lower back and abdomen concentrated on his right side), MYALGIA (achiness), ARTHRALGIA (lower back, hip and abdominal pain) and VACCINATION SITE RASH (slight rash in the injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included mushroom powder pills and comprehensive immune support.The patient took ibuprofen in case it was his herniated disc but it did not help.The patient was also treated with Percocet (oxycodone) and muscle relaxer.  The reporter stated that one nurse at the clinic said it was a reaction to the Moderna COVID-19 vaccine and another nurse said the vaccination might have caused an inflammatory response from his previous herniated disc.   Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.